Highlight Therapeutics announces follow-up results from Phase 2b study of BO-112 + anti-PD... 19/04/2022 Healthcare Access to innovation BO-112 demonstrates potential as new and highly effective second line therapy for melanoma Partners
HealthTech Innovation Days París France Del 12/10/2022 to 14/10/2022 Healthcare Access to innovation Financing
BIOJAPAN 2022 Yokohama and On-line Japan Del 12/10/2022 to 14/10/2022 Healthcare Access to innovation Personalized medicine
MedFit Grenoble France Del 20/09/2022 to 28/09/2022 Healthcare Access to innovation Financing Digitalization
Biomed Israel 2022 (MIXiii Biomed) Tel Aviv Israel Del 10/05/2022 to 12/05/2022 Healthcare Access to innovation
The Medtech Forum Barcelona Spain Del 03/05/2022 to 05/05/2022 Healthcare Access to innovation Industrial biotechnology
3rd Annual MarketsandMarkets Single-Cell Analysis Conference Boston USA Del 23/06/2022 to 24/06/2022 Healthcare Access to innovation
ChinaBIO Partnering Forum Hybrid (Sept 13-14 Beijing, China /Sept 15-16, Virtual) Del 13/09/2022 to 16/09/2022 Access to innovation Change of dates: postponed to September 13-14, Beijing (China) and September 15-16, virtual
Vaccines Manufacturing: COVID-19 and Beyond On-line Del 09/06/2021 to 09/06/2021 Healthcare Access to innovation Coronavirus
